Cypress Capital Management LLC (Wy) Syndax Pharmaceuticals Inc Transaction History

Cypress Capital Management LLC (Wy)

  • $91.7 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022
SELL
$14.84 - $22.15 $74 - $110
-5 Closed
0 $0
Q3 2021

Nov 04, 2021
SELL
$13.87 - $19.8 $1,054 - $1,504
-76 Reduced 93.83%
5 $0
Q1 2021

May 07, 2021
SELL
$19.28 - $24.59 $990,008 - $1.26 Million
-51,349 Reduced 99.84%
81 $2,000
Q4 2020

Jan 29, 2021
BUY
$15.1 - $26.44 $776,593 - $1.36 Million
51,430 New
51,430 $1.14 Million

Others Institutions Holding SNDX

# of Institutions
227
Shares Held
88.3M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $910M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Cypress Capital Management LLC (Wy) Portfolio

Follow Cypress Capital Management LLC (Wy) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC (Wy), based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Management LLC (Wy) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email